During the past decade, Instituto de Ciencias Médicas conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Ciencias Médicas" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ciencias Médicas" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Ciencias Médicas" are "Ulcerative Colitis" (3 trials), "Asthma" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Instituto de Ciencias Médicas" in a lesser frequency.

Most popular intervention types in "Instituto de Ciencias Médicas" are "Drug" (13 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (3 trials), "Tirzepatide" (3 trials), "Dulaglutide" (1 trials) and "GB001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Ciencias Médicas" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Ciencias Médicas". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Instituto de Ciencias Médicas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Ciencias Médicas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".